Latest Breaking News On - James versalovic - Page 1 : comparemela.com

Bad RSV season leaves babies at risk amid antibody shortage

Despite FDA approval, the new RSV antibody, Beyfortus, is in short supply, leaving many infants susceptible to severe respiratory infections.

A new immunization hinted at an end to bad RSV seasons. But an ongoing shortage means babies are still getting sick

As a pulmonary critical care specialist, Dr. Cassondra Cramer-Bour knows intimately what RSV, or respiratory syncytial virus, can do to a person’s lungs.

Ongoing RSV vaccine shortage means babies are still getting sick

Parents have been eagerly awaiting the new immunization, which clinical trials found to be 75% effective at preventing RSV infections severe enough to be seen by a doctor.

Bad RSV season leaves babies at risk amid antibody shortage

Bad RSV season leaves babies at risk amid antibody shortage

Despite FDA approval, the new RSV antibody, Beyfortus, is in short supply, leaving many infants susceptible to severe respiratory infections.